News & Articles 19/01/2024 Our Network Voydeya (danicopan) granted first-ever regulatory approval in Japan for adults with PNH to be used in combination with C5 inhibitor therapy Approval of first-in-class, oral, Factor D inhibitor based on ALPHA Phase III trial in a subset of patients with PNH.
